Pooled Complement Human Serum Reference 6-28-14
Posted by Leanne Kodsman on
Innovative Research's Pooled Complement Human Serum was recently used in the following study:
We conclude that mice have limited utility as models of NMO. 2. Materials and methods. 2.1. Reagents and antibodies. Complement/sera from mouse (CD1 and C57BL/6 strains), rat (Wistar strain), guinea pig and human were purchased from Innovative Research (Novi, MI).
Inhibitor (s) of the classical complement pathway in mouse serum limit the utility of mice as experimental models of neuromyelitis optica
J Ratelade, AS Verkman - Molecular Immunology, 2014We conclude that mice have limited utility as models of NMO. 2. Materials and methods. 2.1. Reagents and antibodies. Complement/sera from mouse (CD1 and C57BL/6 strains), rat (Wistar strain), guinea pig and human were purchased from Innovative Research (Novi, MI).
The next big thing: it's what you do. The biological research materials you need to discover it? That's what we do! We love seeing how our products are being used in real-life applications and contributing to scientific acheivements every day. With thousands of published references and decades of proven results, you can count on us to help you source the high-quality biomaterials you need that will deliver reliable, consistent results - kit to kit, lot to lot, all study long. So what are you waiting for? All great discoveries start somewhere... yours starts with Innovative Research! Get in touch with our team today!
Related Posts
Easy as PAI(-1): Celebrate Pi Day with Cutting-Edge Monoclonal Antibodies from Innovative Research
In the ever-evolving landscape of molecular biology, precision tools are essential for ...
Read the ArticleRevolutionizing Diabetes Treatment: Genetically Engineered Pseudo-Islets Achieve Insulin Independence
In a groundbreaking study, researchers have pioneered a diabetes treatment that could r...
Read the ArticlePioneering Advances in Complement-Mediated Disorders: An In-depth Look at SAR443809
In the dynamic landscape of medical research, SAR443809 emerges as a promising candidat...
Read the Article